Vivo Bio Tech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

17.16

14.90

14.90

14.26

13.42

Share application money

7.27

-

-

0.69

1.43

Preference share capital

-

-

-

-

-

Reserves & surplus

53.75

39.49

36.97

32.19

27.70

Loan funds

Secured loans

51.80

70.84

60.17

65.24

28.73

Unsecured loans

-

-

-

-

-

Total

129.99

125.23

112.04

112.38

71.27

Uses of funds

Fixed assets

Gross block

134.57

120.43

122.53

122.38

74.31

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

49.70

43.41

37.02

30.57

25.62

Net block

84.88

77.01

85.51

91.81

48.69

Capital work-in-progress

12.84

9.21

1.90

0.87

0.32

Investments

0.04

0.04

0.04

0.04

0.04

Net current assets

Current assets, loans & advances

43.53

48.54

33.36

27.58

28.26

Less : current liabilities & provisions

11.30

9.57

8.76

7.91

6.04

Total net current assets

32.23

38.97

24.60

19.67

22.22

Miscellaneous expenses not written

-

-

-

-

-

Total

129.99

125.23

112.04

112.38

71.27

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

171.65

149.04

149.04

142.64

134.20